Pages

Total Pageviews

Observational Notes on Rockwood Holdings Inc.

Journal Entry: 29 Sept. 2013

Rockwood Holdings Inc. Capitalization Rate
in millions except shares outstanding
Closing price: $66.97
Shares Outstanding: 74,701,097
Market value of equity: $5,002.73 M
Debt: $1,294.20 M
Cash & Equivalents: $2,734.60 M
Enterprise Value: $3,562.33 M
EBITDA less CapEx: $164.2 M
Pre-tax Cap Rate: 4.61%


Opinion
  • opportunity to buy an attractive specialty chemical company poised for takeover
  • $80 - $90 LBO target valuation for 2013 & 2014
  • Core businesses: lithium & specialty treatment hold high potential given growth in electronic auto industry
  • Lithium & Specialty treatment businesses hold high market share leadership; Globally No. 1 & No. 2, respectively
  • optimizing pro forma cash on hand through organic growth, accretive acquisitions & return of capital to shareholders
Company

   

Post Asset Sale Restructuring
Competitors
  • continued restructuring of core & non-core businesses allowing for a more focused enterprise
  • increase in market multiple due to specialized and high cash margin business ops.
  • continued goal of maximizing and returning shareholder value from talented executive & operational teams
  • M&A interest for newly restructured company due to realized economic growth
Risk Considerations
  • electric auto industry growth slower than expected
  • Not everyone could do a deal of the company's size, so no M&A interest evolves
  • Unexpected macroeconomic downturn particularly to Europe's auto industry
  • global currency to US dollar issues; largely denominated in Euros
have no positions in the above company mentioned, but may initiate a long position over the next 72 hours.

What Observations have you found on ROC?
Click on comments to Leave your opinion

Observational Notes on Aqua America Inc.

Journal Entry: 23 Sept. 2013

Aqua America Inc. Capitalization Rate
in millions except shares outstanding
Closing price: $24.28
Shares Outstanding: 141,170,775
Market value of equity: $3,427.63 M
Debt: $1,802.64 M
Cash & Equivalents: $4.27 M
Enterprise Value: $5,226 M
EBITDA less CapEx: $-183.47 M
Pre-tax Cap Rate: -3.51%

have no positions in the above company mentioned, but may initiate a long position over the next 72 hours.

What Observations have you found on WTR?
Click on comments to Leave your opinion

Feds, U.S. Economy and Philanthropy w/ Buffett & Moynihan

Buffett Says Fed Is Greatest Hedge Fund in History

Observational Notes on Polycom Inc.

Journal Entry: 17 Sept. 2013

Polycom Inc. Capitalization Rate
in millions except shares outstanding

Shares Outstanding: 169,622,827
Market value of equity: $1,850.59 M
Debt: $0
Cash & Equivalents: $609.89 M
Enterprise Value: $1,240.70 M
EBITDA less CapEx: $42.23 M
Pre-tax Cap Rate: 3.4%

Strategic initiatives in 2012

have no positions in the above company mentioned, but may initiate a long position over the next 72 hours.

What Observations have you found on PlCM?
Click on comments to Leave your opinion

Observational notes on Qualcomm Inc.

Journal entry: 14 Sept. 2013

Qualcomm Inc. Capitalization Rate
in millions except shares outstanding
Closing price: $68.58

Shares Outstanding: 1,715,425,829
Market value of equity: $117,644 M
Debt: $0
Cash & Equivalents: $30,456 M
Enterprise Value: $87,187 M
EBITDA less CapEx: $7,678 M
Pre-tax Cap Rate: 8.80%

have no positions in the above company mentioned, but may initiate a long position over the next 72 hours.

What Observations have you found on QCOM?
Click on comments to Leave your opinion

Observational Notes on Francesca's Holding Corp.

Journal Entry: 13 Sept 2013


Francesca's Holding Corp. Capitalization Rate

in millions except shares outstanding
Closing price: $19.74

Shares Outstanding: 44,090,538
Market value of equity: $870.35 M
Debt: $65.00 M unused revolving credit facility
Cash & Equivalents: $39.55 M
Enterprise Value: $895.80
EBITDA less CapEx: $71.64 M
Pre-tax Cap Rate: 8.00%


have no positions in the above company mentioned, but may initiate a long position over the next 72 hours.

What Observations have you found on FRAN?
Click on comments to Leave your opinion

Observational Notes on AAPL

Journal Entry: 31 Aug 2013

Apple Inc. Capitalization Rate
in millions except shares outstanding
Closing price: $487.22

Shares Outstanding: 908,497,000
Market value of equity: $442,637.91
Debt, fair value: $16,958.00
Cash & Equivalents: 42,606.00
Enterprise Value: $416,989.91
EBITDA less CapEx: $46,197.00

Observational Notes on CSX Corp.

Journal Entry: 19 Aug 2013

CSX Corp. Capitalization Rate
in millions except shares outstanding
Closing price: $24.89

Shares Outstanding: 1,018,837,313
Market value of equity: $25,358.86
Debt, fair value: $10,417.00
Cash & Equivalents: $1,017.00
Enterprise Value: $34,758.86
TTM EBITDA less CapEx: $2,378.00
Pre-tax Cap Rate: 6.84%



have no positions in the above company mentioned, but may initiate a long position over the next 72 hours.
What Observations have you found on CSX?
Click on comments to Leave your opinion.

Observational Notes On Vornado Realty Trust (VNO)

Journal Entry: 12 Aug 2013

Vornado Realty Trust Capitalization Rate
in millions except shares outstanding
Closing price: $83.46

Shares Outstanding: 186,991,076
market value of equity: $15,606.27
Debt, fair value: $10,024.74
Cash & Equivalents: $2,369.18
Enterprise Value: $23,261.83
EBITDA less CapEx: $2,010.91
Pre-tax Cap Rate: 8.64%

From the 2Q 2013 earnings call:
have no positions in the above company mentioned, but may initiate a long position over the next 72 hours.
What Observations have you found on VNO?
Click on comments to Leave your opinion.

Observational Notes on Nordion Inc. (NDZ)

Journal Entry: 12 Aug 2013
Nordion Inc. Capitalization Rate
in millions except shares outstanding
Closing price: $7.59
Shares Outstanding: 61,909,000
market value of equity: $469.89
Debt, fair value: $42.36
Cash & Equivalents: $81.53
Enterprise Value: $430.72
normalized EBITDA less CapEx: $17.23
Pre-tax Cap Rate: 4.00%

  • Agreement signed on May 23, 2013 to divest the Targeted Therapies business to BTG plc (BTG) for a cash purchase price of $200 million
  • From Mr.Steve West, Chief Executive Officer, Nordion Inc., "...made progress on our strategic review, reaching an agreement to divest the Targeted Therapies business to BTG, which we believe unlocks value for our shareholders and leaves us with a focused specialty isotopes business going forward."
  • Company generated an increase of $6.1 million, or 12%, over revenue of $50.0 million for the same period in fiscal 2012
  • Specialty Isotopes: Sterilization Technologies - $20.2 million revenue up 36% compared to Q2 2012
  • Cash & Liquidity position bolstered from sale; $51.7 million of deferred tax assets and $185 million additional cash upon close of sale unaccounted in above Pre-tax Cap Rate











  • have no positions in the above company mentioned, but may initiate a long position over the next 72 hours.
    What Observations have you found on NDZ?
    Leave your comments.

    Support my Page. Order from Stella&Dot Stylist Arrie Bernard

    Support my Page. Order from Stella&Dot Stylist Arrie Bernard
    Support my Page. Order from Stella&Dot Stylist Arrie Bernard